Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra J Lee

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Cancer Treatment and Research|March 5, 2003
Models and the early detection of disease: methodological considerationsMarvin Zelen, Sandra J Lee
Cancer Treatment and Research|March 5, 2003
Statistical models for screening: planning public health programsSandra J Lee, Marvin Zelen
Biometrics|August 30, 2007
Mortality modeling of early detection programsSandra J Lee, Marvin Zelen
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2018
The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An UpdateSandra J Lee, Xiaoxue Li, Hui Huang, et al.
Cancer|May 9, 2019
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanomaYana G Najjar, Maneka Puligandla, Sandra J Lee, et al.
American Journal of Clinical Pathology|March 17, 2010
Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trialsUma N M Rao, Sandra J Lee, Weixiu Luo, et al.
Melanoma Research|February 11, 2014
Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfaAhmad A Tarhini, Donghoon Shin, Sandra J Lee, et al.
Journal of the American Academy of Dermatology|January 18, 2019
Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomasLauren C Strazzulla, Xiaoxue Li, Kathleen Zhu, et al.
The Journal of Investigative Dermatology|June 3, 2016
Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011)Julie S Najita, Susan M Swetter, Alan C Geller, et al.
Nature|November 25, 2005
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infectionDeborah Palliser, Dipanjan Chowdhury, Qing-Yin Wang, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Cancer Treatment and Research|March 5, 2003
Models and the early detection of disease: methodological considerationsMarvin Zelen, Sandra J Lee
Cancer Treatment and Research|March 5, 2003
Statistical models for screening: planning public health programsSandra J Lee, Marvin Zelen
Biometrics|August 30, 2007
Mortality modeling of early detection programsSandra J Lee, Marvin Zelen
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2018
The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An UpdateSandra J Lee, Xiaoxue Li, Hui Huang, et al.
Cancer|May 9, 2019
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanomaYana G Najjar, Maneka Puligandla, Sandra J Lee, et al.
American Journal of Clinical Pathology|March 17, 2010
Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trialsUma N M Rao, Sandra J Lee, Weixiu Luo, et al.
Melanoma Research|February 11, 2014
Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfaAhmad A Tarhini, Donghoon Shin, Sandra J Lee, et al.
Journal of the American Academy of Dermatology|January 18, 2019
Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomasLauren C Strazzulla, Xiaoxue Li, Kathleen Zhu, et al.
The Journal of Investigative Dermatology|June 3, 2016
Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011)Julie S Najita, Susan M Swetter, Alan C Geller, et al.
Nature|November 25, 2005
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infectionDeborah Palliser, Dipanjan Chowdhury, Qing-Yin Wang, et al.
Pageof 9